← Back to Search

Procedure

Microneedling and Serum for Acne

Phase 2 & 3
Waitlist Available
Research Sponsored by Equipmed USA LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects who agree not to use any other product/treatment/home remedy/ except the provided products on their face during the study period
Female subjects aged between 18-45 years (both ages inclusive)
Must not have
Subjects with active Herpes labialis infection
Subjects with any other signs of significant local irritation or skin disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 weeks
Awards & highlights
No Placebo-Only Group

Summary

"This trial is testing the effectiveness of using the Dermapen 4™ microneedling device with MG-CLR serum for treating acne over a 12-week period."

Who is the study for?
This trial is for individuals with acne who are looking to improve their skin condition. Specific eligibility criteria have not been provided, so it's best to contact the study organizers for detailed requirements.
What is being tested?
The effectiveness of Dermapen 4™ microneedling device in combination with MG-CLR serum is being tested over a period of 12 weeks to treat acne.
What are the potential side effects?
While specific side effects are not listed, common ones from microneedling can include redness, irritation at the treatment site, and slight swelling. The serum may also cause skin reactions depending on its ingredients.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I agree to only use the provided products on my face during the study.
Select...
I am a woman aged between 18 and 45.
Select...
My face is free from excessive hair and any skin conditions.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I currently have an active cold sore infection.
Select...
I have significant skin irritation or a skin condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acne severity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: A single arm, full face clinical study.Experimental Treatment1 Intervention
Dermapen 4 in conjunction with MG-CLR serum

Find a Location

Who is running the clinical trial?

Equipmed USA LLCLead Sponsor
~6 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top